Edwards CEO talks innovation and regulation on Capitol Hill

Edwards Lifesciences chairman & CEO Michael Mussallem warns Congress that healthcare regulators and payers are cultivating an "alarming and documented decline in U.S. medical innovation."

Edwards Lifesciences, U.S. Congress, U.S. House of Representatives

News Well, Capitol Hill, 510(k) reforms, Lobbying, Regulatory

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oL1b3w